IgG4-related disease: a primer on diagnosis and management
Annals of Allergy, Asthma & Immunology
June 2015 Volume 114, Issue 6, Pages 447-454 CME Review
Participants will be able to demonstrate increased knowledge of the clinical treatment of allergy/asthma/immunology and how new information can be applied to their own practice
Accreditation: The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation: The American College of Allergy, Asthma & Immunology (ACAAI) designates this journal-based CME activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Planning Committee Members
Jack G. Ghably, MD, (Author)
Mitchell H. Grayson, MD (CME Series Editor, Deputy Editor)
Gailen D. Marshall, Jr, MD, PhD (Editor-in-Chief)
Physicians involved in providing patient care in the field of allergy/asthma/immunology
At the conclusion of this activity, participants should be able to:
Describe the various clinical manifestations and identify the histopathological hallmarks characteristic of IgG4-related disease
Discuss the management options for patients diagnosed with IgG4-related disea
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Attendance